Behnood Bikdeli and Colleagues Summarize 2025 ACC/AHA Recommendations for Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared an insightful post on X:
“We summarized the guideline recs for anticoagulant and antiplatelettherapy in ACS and compared them with prior recs in ACCinTouch, AHAScience and escardio guidelines. Writing Committee and also a great team who made this summary possible.”
Title: Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations
Auhors: Behnood Bikdeli, Francisco Ujueta, Sina Rashedi, Azita H. Talasaz, Kushal T. Kadakia, Renato D. Lopes, Harvey D. White, Philippe Gabriel Steg, Gregory Piazza, Rasha K. Al-Lamee, David J. Cohen, Roxana Mehran, and Harlan M. Krumholz
Read the full article here.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?